Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin
Author:
Funder
VA Distinguished Scientist Award
VA
VA Research Service
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00408-019-00257-w.pdf
Reference40 articles.
1. Lederer D, Martinez F (2018) Idiopathic pulmonary fibrosis. N Engl J Med 378:1811–1823
2. Schwartz D (2016) Idiopathic pulmonary fibrosis is a complex genetic disorder. Trans Am Clin Climatol Assoc 127:34–45
3. Herrera J, Henke C, Bitterman P (2018) Extracellular matrix as a driver of progressive fibrosis. J Clin Invest 128:45–53
4. Wei Y, Kim T, Peng D, Duan D, Gibbons D, Yamauchi M, Jackson J, Le Saux C, Calhoun C, Peters J, Derynck R, Backes B, Chapman H (2017) Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis. J Clin Invest 127:3675–3688
5. Kiaris H, Chatzistamou I, Papavassiliou A, Schally A (2011) Growth hormone-releasing hormone: Not only a neurohormone. Trends Endocrinol Metab 22:311–317
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Growth hormone–releasing hormone receptor antagonist MIA-602 attenuates cardiopulmonary injury induced by BSL-2 rVSV-SARS-CoV-2 in hACE2 mice;Proceedings of the National Academy of Sciences;2023-11-20
2. Growth hormone‐releasing hormone beyond cancer;Clinical and Experimental Pharmacology and Physiology;2023-09-26
3. Alveolar epithelial cell growth hormone releasing hormone receptor in alveolar epithelial inflammation;Experimental Lung Research;2023-08-16
4. Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells;Frontiers in Immunology;2023-08-15
5. Unfolded protein response suppression potentiates LPS-induced barrier dysfunction and inflammation in bovine pulmonary artery endothelial cells;Tissue Barriers;2023-07-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3